Pharamcokinetics: Course In-Charge: Nimra Waheed Course Name: Biopharmaceutics and Pharmacokinetics Course Code: 613-T
Pharamcokinetics: Course In-Charge: Nimra Waheed Course Name: Biopharmaceutics and Pharmacokinetics Course Code: 613-T
Let us consider a hypothetical situation wherein 2 drugs are given by an I.V. bolus in
equal pl
doses. One drug is 90% protein bound whereas the other drug does not bind to the
asma protein and both are eliminated solely by glomerular filtration through the kidney.
Plasma Drug A
drug
level
Time in hrs
Plasma drug level – time profile of two drugs given in equal
18
doses
In the above plot drug A represents 90% bound to plasma protein,
curve B represents a drug not bound to plasma protein.
The protein bound drug is more concentrated in plasma than the drug
that is
low and hence, its elimination rate will be slow when compared with the drug that
does not bind to plasma protein. Further, the protein bound drug shows a non-linear
elimination whereas the drug that is not bound to the plasma protein shows a linear
elimination.
19
A careful elimination of curve A reveals that the slope of the bound
drug decreases gradually as the drug concentration decreases. It means that
the free drug concentration decreases and bound drug concentration increases as the
total drug concentration in plasma decreases. In other words, the ratio of the bound
drug to free drug is not constant but increases at a low plasma concentration of the
drug. Therefore, fitting the plasma concentration-time data of a protein-bound drug
into a simple one compartment model without accounting for protein binding results
in an erroneous estimation of volume of distribution & half life.
20
NON-LINEARITY OF PHARMACOLOGICAL
RESPONSES
saturable absorption
Saturable elimination
21
Drug Absorption :-
When absorption is dissolution rate limited Ex:-
Griseofulvin.
When absorption involves carrier mediated transport system
Ex:-absorption of riboflavin ,ascorbic acid,cyanocobalamine .
When presystemic gut wall or hepatic metabolism attains
saturation
Ex:- propranalol ,hydralazine and verapamil.
Changes in gastric emptying and GI blood flow also cause
nonlinearity.
Drug Distribution :-
Saturation of binding sites on plasma proteins Ex:- Phenyl
butazone.
Saturation of tissue binding sites Ex:- Thiopental.
Drug Metabolism :-
Capacity limited metabolism due to enzyme or cofactor
saturation Ex:-phenytoin.
Enzyme induction Ex:-carbamazepine.
Saturation of binding sites ,inhibitory effect of the
metabolite on enzyme and pathological situations
and changes in hepatic blood flow.
Drug Excretion :-
Active tubular secretion Ex:- penicillin G.
Active tubular reabsorption Ex:- Glucose and water
soluble vitamins.
Forced diuresis,changes in urine pH,nephrotoxicity and
saturation of binding sites.
Nonlinear pharmacokinetics can be best described by
Michaelis Menten Equation.
-dC/dt = Vmax C / Km + C
Where,
-dC/dt = rate of decline of drug conc. With time.
Vmax = theoretical max. rate of process.
= michaelis constant.
Km
SUMMARY
• We have discussed linear and non-linear pharmacokinetics.
• We have discussed the concept, and its application in clinical studies.
REFERENCE BOOKS
• Biopharamaceutics and Clinical pharmacokinetics by Milo Gibaldi
• Applied biopharmaceutics and pharmacokinetics Textbook by Leon Shargel
• Pharmacokinetic-pharmacodynamic modeling and simulation Book by Peter L. Bonate
• Essentials of Biopharmaceutics and Pharmacokinetics Book by Ashutosh Kar
• Pharmacokinetics: Principles and Applications by Mehdi Boroujerdi
• Basic Pharmacokinetics by Mohsen A. Hedaya
• Clinical Pharmacokinetics: Concepts and Applications by Malcolm Rowland, Thomas N.
Tozer
• Biopharmaceutics and Pharmacokinetics Book by A. P. Pawar and J. S. Kulkarni